Aaruni Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-12-2024
- Paid Up Capital ₹ 1.48 M
as on 04-12-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Aaruni Lifesciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.48 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Aaruni Lifesciences Private Limited India is Shashikanth Shivaram as CEO. Sama Satyavathi, Mulky Kamath, Shashikanth Shivaram, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999KA2021PTC146762
- Company No.
146762
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aaruni Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashikanth Shivaram  | CEO | 05-Feb-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sama Satyavathi | Director | 01-Jun-2024 | Current |
| Mulky Kamath | Director | 20-Apr-2021 | Current |
| Shashikanth Shivaram | Director and Ceo | 05-Feb-2022 | Current |
| Saideep Rathnam | Director | 20-Jul-2022 | Current |
| Prasanna Joshi | Director | 01-Jun-2024 | Current |
Financial Performance of Aaruni Lifesciences.
Enhance accessibility to Aaruni Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aaruni Lifesciences?
Unlock access to Aaruni Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aaruni Lifesciences?
Aaruni Lifesciences has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaruni Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaruni Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
